Tolvaptan for treating autosomal dominant polycystic kidney disease

  • Technology appraisal guidance
  • TA358
  • Published: 
Download guidance (PDF)

Update information

December 2015: Factual accuracy changes made to the evidence (sections 3.53, 3.55 and 3.56) and considerations (sections 4.12, 4.13, 4.16 and 4.17).

ISBN: 978-1-4731-1485-2